title: Methylprednisolone-induced immune thrombocytopenia.
authors.forename: Bruno
authors.initials: B
authors.lastname: Royer
authors.forename: Ketty
authors.initials: K
authors.lastname: Lee
authors.forename: Berengere
authors.initials: B
authors.lastname: Gruson
authors.forename: France
authors.initials: F
authors.lastname: Roszkiewicz
authors.forename: Abdullatif
authors.initials: A
authors.lastname: Al Khedr
authors.forename: Agnes
authors.initials: A
authors.lastname: Colson
authors.forename: Agnes
authors.initials: A
authors.lastname: Camboulives
authors.forename: Philippe
authors.initials: P
authors.lastname: Bierling
authors.forename: Jean Pierre
authors.initials: JP
authors.lastname: Marolleau
mesh_terms: D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000009:adverse effects*; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000009:adverse effects*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000139:chemically induced / Q000188:drug therapy / Q000276:immunology; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology*
chemical_list: D018696:Neuroprotective Agents; D008775:Methylprednisolone